Abdominal Wall Transplant

Status Recruiting

Clinical Trial Summary

The purpose of this protocol is to determine the safety and efficacy of abdominal wall transplantation as a treatment for the reconstruction of abdominal wall defects. Abdominal wall transplantation may be performed alone or in combination with another transplant.

Clinical Trial Description

Within this protocol we propose to perform abdominal wall transplantation in 5 subjects, either as an isolated abdominal wall or in combination with another organ transplant. Each subject will be followed for a study period of 18 months. Participants receiving an isolated abdominal wall or abdominal wall in combination with another organ transplant will receive the standard immunosuppression therapy as the non-vascularized composite allograft organ transplant. These patients will be studied to determine efficacy of the abdominal wall transplant to restore function of the defective abdominal wall for a study period of 18 months at Duke University Medical Center. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03310905
Study type	Interventional
Source	Duke University
Contact	Linda Cendales, MD
Phone	919-681-7514
Email	linda.cendales@duke.edu
Status	Recruiting
Phase	N/A
Start date	May 1, 2018
Completion date	June 1, 2028

View Details

See also
Status	Clinical Trial	Phase
Withdrawn	`NCT05811468` - Study Correlation Between Blood, Tissue Gene Expression, Donor Derived Cell Free DNA and Histopathology in Kidney Transplant Recipients
Active, not recruiting	`NCT04166149` - Eliminating the Need for Pancreas Biopsy Using Peripheral Blood Cell-free DNA
Completed	`NCT03723668` - Kidney Transplant Outcome and Organ Acceptance Practice Pattern: A Nationwide Analyses in the US and France
Recruiting	`NCT03737604` - TAP Blocks With Ropivacaine Continuous Infusion Catheters vs Single Dose Liposomal Bupivicaine After Kidney Transplant	Phase 4
Completed	`NCT03765203` - Utility of a Novel Dd-cfDNA Test to Detect Injury in Renal Post-Transplant Patients	N/A
Completed	`NCT05809440` - Effectiveness of 20m-MB in KTR Symptom Control	N/A
Enrolling by invitation	`NCT04491227` - Global Assessment of Acute and Chronic Kidney Disease Incidence and Outcomes in Patients With COVID-19 Infection
Not yet recruiting	`NCT06396702` - EASE-SOT Pilot Study	N/A
Recruiting	`NCT05613010` - Leveraging Technology to Improve Medication Adherence in Youth With Kidney or Liver Transplant	N/A
Recruiting	`NCT06263257` - The Effect of Mandala Therapy on Anxiety and Comfort in Kidney Transplant Recipients	N/A
Completed	`NCT04715412` - Clinical Pharmacy Guided Patient Counselling and Adherence Support on Renal Transplant Recipients	N/A
Active, not recruiting	`NCT05449496` - Dietary Intervention to Improve Kidney Transplant Outcomes	N/A
Not yet recruiting	`NCT06089473` - Virtual Home-based Physical Pre-habilitation in Kidney Transplant Candidates	N/A
Withdrawn	`NCT04473924` - Standard Therapy or Individualized Immunosuppression For Lowering Adverse Event Risk	Phase 2
Recruiting	`NCT04619732` - Real-time Monitoring of Kidney Grafts on Hypothermic Machine Perfusion	N/A
Completed	`NCT03760263` - Evaluation Dose Adjustments in Kidney Transplant Patients on Immediate Release and Extended Release Tacrolimus	Phase 4
Active, not recruiting	`NCT03380962` - Clazakizumab in Highly-HLA Sensitized Patients Awaiting Renal Transplant	Phase 1/Phase 2
Active, not recruiting	`NCT03436368` - Continuous Spinal Anesthesia in Renal Transplantation	N/A
Not yet recruiting	`NCT03322709` - Minimally Invasive Kidney Transplantation	N/A
Recruiting	`NCT03778944` - Enhancing Renal Graft Function During Donor Anesthesia	N/A